Also, Icam1−/−Apoe−/− mice were shown to have significantly reduced atherosclerotic lesions, and soluble levels of ICAM-1 paralleled atherosclerosis progression in Apoe−/− mice with significantly elevated plasma concentrations compared to experiment onset (211). This evidence concerns the gene ICAM1 and atherosclerosis.